Autopsy report · NCT05259800

Peppermint Oil for Urinary Retention

“Difficulty enrolling patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months after it had already started.
• Ran for about 3 years 6 months before it stopped.
• 17 participants enrolled.
• Results were posted on the registry 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

TriHealth Inc.

Sponsor type

University, hospital or other

Conditions

Urinary Retention

Interventions

Peppermint oil vapors; Mineral Oil

Participants

17

Sites

1

Countries

United States

Trials that died the same way

• Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer
  “Difficulty in enrolling patients” (99% match in meaning)
• Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
  “difficulty of enrolling patients” (95% match in meaning)
• Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
  “Unable to enroll appropriate patients” (90% match in meaning)
• The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus
  “Unable to enroll patients” (90% match in meaning)
• In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema Patients
  “Difficulty in enrolling new patients” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.